Get Ready, Get Set…and Go! The January 6, 2020 Implementation and compliance date for the FMCSA Drug and Alcohol Clearinghouse is less than 90 days away. Below is some information and a checklist for making sure you are on track for January 6, 2020: REGISTER NOW – Register in the […]
We invite you to join us as we discuss the upcoming Clearinghouse, it’s predicted effects on the transportation industry, and what you need to know to make sure you are in compliance. Presented by industry veteran and WFQA Director of Compliance & Regulatory Affairs, Donna Smith Ph.D., this webinar is not […]
We recently held a Webinar about DOT MRO Safety Concerns. Here is a copy of the questions that were asked during the webinar and our answers/guidance. Click Here
Chief Medical Review Officer, Paul Teynor, MD, to be named Chief Medical Officer of WorkforceQA After more than 28 years of providing Medical Review Officer (MRO) services, Paul Teynor, MD, Chief Medical Review Officer and Chief Medical Officer of WorkforceQA, LLC. will be reducing his involvement in day-to-day activities effective January […]
We have recently begun transitioning accounts to a new account management platform. While this transition will provide a higher level of service and an improved customer experience, we recognize that some may be experiencing service issues. If you are experiencing delays or issues with your service, please contact our client services […]
We had great attendance and participation during our webinars on the new DOT rule concerning the expanded testing panel and what it means for employers. We have compiled all the questions we received and have provided our answers. Please click below to access the Q&A document from the webinar. Thanks […]
In case you missed it, below is a link to the webinar we hosted about the expanded DOT panel and what this new rule means for employers. For more information, please check out our other blog posts. Click Here to View Webinar Username: guest Password: webinar
Please join us for a free webinar on the new 49 CFR Part 40 final rule that was published Nov 13, 2017, by the DOT. This rule expands DOT drug testing to include opioids, hydrocodone, hydromorphone, oxycodone, and oxymorphone and is effective January 1, 2018. Our compliance experts, Dr. Donna Smith and Sandra Vanderploeg, will be arming you with all the […]
The long-awaited revisions to 49 CFR Part 40 were published November 13, 2017. The final rule caps a nine months rulemaking process by the DOT and is in effect January 1, 2018. The rule primarily harmonizes DOT regulations with the revised HHS Mandatory Guidelines established by the U.S. Department of […]
The long-anticipated expansion of the drug testing panel to include the opioid drugs (i.e., hydrocodone, hydromorphone, oxycodone and oxymorphone) for DOT-mandated testing will NOT take place on October 1, 2017. The DOT will continue its rulemaking process to issue a final rule revising 49 CFR Part 40, and once complete, […]